SSE Ticker: 603896

Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

寿仙谷

Authorized Representative: 李明焱

Board: Main A

Industry Classification: Manufacturing

Huaan Securities: Buy rating for Shouxiangu

Post date May 16, 2022 — 10:12 Post Lock

Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated

Post date May 16, 2022 — 08:44 Post Lock

Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains

Post date May 10, 2022 — 10:07 Post Lock

Institutions strongly recommend 8 stocks-Update-CFi.CN Zhongcai Network

Post date May 7, 2022 — 00:45 Post Lock

Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery

Post date May 6, 2022 — 22:37 Post Lock

The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry

Post date May 6, 2022 — 18:35 Post Lock

Institutions strongly recommend 2 stocks-Update-CFi.CN Zhongcai Network

Post date May 6, 2022 — 16:10 Post Lock

Medicine: The new crown nucleic acid test is normalized, the economy is stabilized, and the business recovery of the leading companies in the high-prosperity track is optimistic after the epidemic period – yqqlm

Post date May 5, 2022 — 08:20 Post Lock

Huabao Pension ETF Net Value Gains 3.67%

Post date April 30, 2022 — 08:15 Post Lock

Pharmaceutical and Biological Industry Weekly Report: Internal and external disturbances in pharmaceutical stock prices need to continue to select pharmaceutical stocks for layout – yqqlm

Post date April 25, 2022 — 10:45 Post Lock

Pharmaceutical Industry Weekly Report: Short-term irrational sadness in medicine, long-lasting can be more joyful, postal courier tracking number, postal courier inquiry, postal courier parcel inquiry, postal courier parcel inquiry

Post date April 24, 2022 — 15:31 Post Lock

Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be doubled in the medium and long term.

Post date April 24, 2022 — 15:31 Post Lock

Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be more optimistic in the medium and long term

Post date April 24, 2022 — 15:31 Post Lock

New Fortune Analyst Annual Meeting and High-end Capital Market Summit of Huangpu District Guangzhou Development Zone kicks off-News Channel-Hexun.com

Post date April 22, 2022 — 21:00 Post Lock

[Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of SPDB-AXA Healthcare Hybrid A Fund_Oriental Fortune Network

Post date April 22, 2022 — 15:29 Post Lock

Chinese medicine can make a difference! Zuoli Pharmaceutical's performance has continuously increased significantly, and R&D investment needs to be increased.

Post date April 21, 2022 — 10:07 Post Lock

GF Pension Index A Net Worth Up 3.06%

Post date April 13, 2022 — 07:44 Post Lock

GF Pension Index C Net Worth Up 3.05%

Post date April 13, 2022 — 07:40 Post Lock

Huabao Pension ETF Net Value Gains 3.34%

Post date April 13, 2022 — 07:16 Post Lock

Southwest Securities released a research report on Shouxiangu: Q1 profit growth exceeded expectations, and expansion outside the province continued to advance – yqqlm

Post date April 7, 2022 — 21:03 Post Lock

Want to see more data? Registered subscribers can see all the data.